Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Thrombocytopenia and TP53[original query] |
|---|
| Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients. The pharmacogenomics journal 2010 Feb 10 (1): 54-61. Khrunin A V, Moisseev A, Gorbunova V, Limborska |
| Clinical effect of point mutations in myelodysplastic syndromes. The New England journal of medicine 2011 Jun 364 (26): 2496-506. Bejar Rafael, Stevenson Kristen, Abdel-Wahab Omar, Galili Naomi, Nilsson Björn, Garcia-Manero Guillermo, Kantarjian Hagop, Raza Azra, Levine Ross L, Neuberg Donna, Ebert Benjamin |
| Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C? Leukemia & lymphoma 2014 Jun 55 (6): 1261-5. Visco Carlo, Cortelezzi Agostino, Moretta Francesca, Falisi Erika, Maura Francesco, Finotto Silvia, Barcellini Wilma, Ambrosetti Achille, Neri Antonino, Ruggeri Marco, Rodeghiero Frances |
| Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 May 26 (5): 1012-8. Fu S, Hou M M, Naing A, Janku F, Hess K, Zinner R, Subbiah V, Hong D, Wheler J, Piha-Paul S, Tsimberidou A, Karp D, Araujo D, Kee B, Hwu P, Wolff R, Kurzrock R, Meric-Bernstam |
| Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi. Leukemia & lymphoma 2018 Apr 1-7. Zaja Francesco, Salvi Flavia, Rossi Maura, Sabattini Elena, Evangelista Andrea, Ciccone Giovannino, Angelucci Emanuele, Gaidano Gianluca, Zanni Manuela, Ladetto Marco, Chiappella Annalisa, Vitolo Umberto, Zinzani Pier Luigi, Califano Catello, Tucci Alessandra, Patti Caterina, Pileri Stefano A, Lenti Valentina, Piccaluga Pier Paolo, Cavallo Federica, Volpetti Stefano, Perali Giulia, Assouline Sarit, Mann Koren Kathleen, Morin Ryan, Alcaide Miguel, Bushell Kevin, Fanin Renato, Levis Alessand |
| A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours. British journal of cancer 2018 12 120 (3): 286-293. de Weger Vincent A, de Jonge Maja, Langenberg Marlies H G, Schellens Jan H M, Lolkema Martijn, Varga Andrea, Demers Brigitte, Thomas Koruth, Hsu Karl, Tuffal Gilles, Goodstal Samantha, Macé Sandrine, Deutsch Er |
| Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies. Scientific reports 2020 2 10 (1): 3080. Wang Yudong, Janku Filip, Piha-Paul Sarina, Hess Kenneth, Broaddus Russell, Liu Lidong, Shi Naiyi, Overman Michael, Kopetz Scott, Subbiah Vivek, Naing Aung, Hong David, Tsimberidou Apostolia M, Karp Daniel, Yao James, Fu Siqi |
| Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer. Oncotarget 2020 2 11 (1): 15-21. Moses Marcus, Koksal Ulkuhan, Ledet Elisa, Manogue Charlotte, Cotogno Patrick, Lewis Brian, Layton Jodi, Sartor A Oliver, Barata Ped |
| Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3K? inhibitor therapy. Blood 2020 12 137 (20): 2817-2826. Mato Anthony R, Ghosh Nilanjan, Schuster Stephen J, Lamanna Nicole, Pagel John M, Flinn Ian W, Barrientos Jacqueline C, Rai Kanti R, Reeves James A, Cheson Bruce D, Barr Paul M, Kambhampati Suman, Lansigan Frederick, Pu Jeffrey J, Skarbnik Alan P, Roeker Lindsey, Fonseca Gustavo A, Sitlinger Andrea, Hamadeh Issam S, Dorsey Colleen, LaRatta Nicole, Weissbrot Hanna, Luning Prak Eline T, Tsao Patricia, Paskalis Dana, Sportelli Peter, Miskin Hari P, Weiss Michael S, Svoboda Jakub, Brander Danielle |
| Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2021 12 22 (12): 3809-3815. Nairuz Tahsin, Bushra Yearul Umme, Kabir Year |
| Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer. Dose-response : a publication of International Hormesis Society 0 20 (2): 15593258221111666. Spasic Jelena, Cavic Milena, Stanic Nemanja, Zaric Bojan, Kovacevic Tomi, Radosavljevic Davorin, Nagorni-Obradovic Ljudmi |
| Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study. Journal of cancer research and clinical oncology 2022 6 . Zhang Lan, Ye Xingnong, Luo Shuna, Xu Xiaofei, Wang Shengjie, Jin Keyi, Zheng Yan, Zhu Xiaoqiong, Chen Dan, Jin Jie, Huang Ji |
| Prediction of survival with intensive chemotherapy in acute myeloid leukemia. American journal of hematology 2022 4 97 (7): 865-876. Sasaki Koji, Ravandi Farhad, Kadia Tapan, DiNardo Courtney, Borthakur Gautam, Short Nicholas, Jain Nitin, Daver Naval, Jabbour Elias, Garcia-Manero Guillermo, Khoury Joseph, Konoplev Sergej, Loghavi Sanam, Patel Keyur, Montalban-Bravo Guillermo, Masarova Lucia, Konopleva Marina, Kantarjian Hag |
| Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. Leukemia 2022 4 36 (6): 1654-1665. Wong Jonathan, Gruber Emily, Maher Belinda, Waltham Mark, Sabouri-Thompson Zahra, Jong Ian, Luong Quinton, Levy Sidney, Kumar Beena, Brasacchio Daniella, Jia Wendy, So Joan, Skinner Hugh, Lewis Alexander, Hogg Simon J, Vervoort Stephin, DiCorleto Carmen, Uhe Micheleine, Gamgee Jeanette, Opat Stephen, Gregory Gareth P, Polekhina Galina, Reynolds John, Hawkes Eliza A, Kailainathan Gajan, Gasiorowski Robin, Kats Lev M, Shortt Ja |
| Integrated clinical genotype-phenotype characteristics of early T-cell precursor acute lymphoblastic leukemia. Cancer 2022 Oct . Ye Matthew T, Wang Yi, Zuo Zhuang, Calin Steliana, He Hua, Tang Zhenya, Jabbour Elias J, Borthakur Gautam, Zhang Yizhuo, Yang Yaling, You M Jam |
| Thirty-Year-Old Male Patient with Non-Seminoma and Coincidental Rectal Cancer. Urologia internationalis 2023 1 1-3. Nolting Julia, Dräger Desiree Louise, Hakenberg Oliver W, Schneidewind Lai |
| [A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2024 12 46 (11): 1038-1048. J Du, X Qiu, J Y Ni, Q L Wang, F Tong, H Z Sha, Y H Zhu, L Qi, W Cai, C Gao, X W Wei, M B Chen, Z Y Qian, M H Cai, M Tao, C L Wang, G C Zheng, H Jiang, A W Dai, J Wu, M H Zhao, X Q Li, B Lu, C B Wang, B R L |
| Overall survival in TP53-mutated AML and MDS. Annals of hematology 2024 10 . Christian J Puzo, Karl M Hager, Henry M Rinder, Olga K Weinberg, Alexa J Sidd |
- Page last reviewed:Feb 1, 2024
- Content source: